Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Albendazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A known ✓ | P04350 | 6/20 | 0.58 |
| ▸ | TUBB known ✓ | P07437 | 6/20 | 0.58 |
| ▸ | TUBA3C known ✓ | P0DPH7 | 6/20 | 0.58 |
| ▸ | TUBA1B known ✓ | P68363 | 6/20 | 0.58 |
| ▸ | TUBA4A known ✓ | P68366 | 6/20 | 0.58 |
| ▸ | TUBB4B known ✓ | P68371 | 6/20 | 0.58 |
| ▸ | TUBB3 known ✓ | Q13509 | 6/20 | 0.58 |
| ▸ | TUBB2A known ✓ | Q13885 | 6/20 | 0.58 |
| ▸ | TUBB8 known ✓ | Q3ZCM7 | 6/20 | 0.58 |
| ▸ | TUBA3E known ✓ | Q6PEY2 | 6/20 | 0.58 |
| ▸ | TUBA1A known ✓ | Q71U36 | 6/20 | 0.58 |
| ▸ | TUBA1C known ✓ | Q9BQE3 | 6/20 | 0.58 |
| ▸ | TUBB6 known ✓ | Q9BUF5 | 6/20 | 0.58 |
| ▸ | TUBB2B known ✓ | Q9BVA1 | 6/20 | 0.58 |
| ▸ | TUBB1 known ✓ | Q9H4B7 | 6/20 | 0.58 |
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.47 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 8/20 | 0.91 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.91 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.91 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Albendazole SCHEMBL31704207 | 0.96 | LMNA (1.00) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL247151 | 0.96 | LMNA (1.00) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL29612190 | 0.88 | LMNA (0.85) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL28470926 | 0.87 | LMNA (0.73) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| SCHEMBL7258034 | 0.87 | LMNA (0.83) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL7969988 | 0.86 | LMNA (0.83) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL29409236 | 0.86 | LMNA (0.83) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL44682 | 0.86 | LMNA (0.83) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL23038783 | 0.86 | LMNA (0.74) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 | |
| Albendazole SCHEMBL28582887 | 0.85 | LMNA (0.81) | LMNACYP1A2MAPK1SMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1379242-A4 | METHOD FOR TREATMENT OF CANCER AND COMPOSITIONS FOR USE THEREIN | NEWSOUTH INNOVATIONS PTY LTD (AU) | 2007-10-03 | — | — | EP | disclosed |
| EP-1379242-A1 | METHOD FOR TREATMENT OF CANCER AND COMPOSITIONS FOR USE THEREIN | UNISEARCH LIMITED (AU) | 2004-01-14 | — | — | EP | disclosed |
| WO-2002076454-A1 | METHOD FOR TREATMENT OF CANCER AND COMPOSITIONS FOR USE THEREIN | UNISEARCH LIMITED (AU) | 2002-10-03 | — | — | WO | disclosed |